Skip to main content
PMC home page
BMC Cancer logoLink to BMC Cancer
. 2020 Feb 17;20:128. doi: 10.1186/s12885-020-6632-y

Correction to: Standard (8 weeks) vs long (12 weeks) timing to minimally-invasive surgery after NeoAdjuvant Chemoradiotherapy for rectal cancer: a multicenter randomized controlled parallel group trial (TiMiSNAR)

Igor Monsellato 1,✉, Filippo Alongi 2, Elisa Bertocchi 2, Stefania Gori 2, Giacomo Ruffo 2, Elisa Cassinotti 3, Ludovica Baldari 3, Luigi Boni 3, Graziano Pernazza 4, Fabio Pulighe 5, Carlo De Nisco 5, Roberto Perinotti 6, Emilio Morpurgo 7, Tania Contardo 8, Enzo Mammano 7, Ugo Elmore 9, Roberto Delpini 9, Riccardo Rosati 9, Federico Perna 10, Andrea Coratti 10, Benedetta Menegatti 10, Sergio Gentilli 11, Paolo Baroffio 11, Piero Buccianti 12, Riccardo Balestri 12, Cristina Ceccarelli 12, Valter Torri 13, Davide Cavaliere 14, Leonardo Solaini 14, Giorgio Ercolani 14, Elena Traverso 1, Vittorio Fusco 1, Maura Rossi 1, Fabio Priora 1, G Numico 1, Paola Franzone 1, Sara Orecchia 1
PMCID: PMC7026949  PMID: 32066408

Correction to: BMC Cancer

https://doi.org/10.1186/s12885-019-6271-3

Following publication of the original article [1], the authors reported that the family name of the author, Ludovica Baldari, was misspelled.

Incorrect:

Ludovica Baldarti

Correct:

Ludovica Baldari

Reference

  • 1.Monsellato I, Alongi F, Bertocchi E, et al. Standard (8 weeks) vs long (12 weeks) timing to minimally-invasive surgery after NeoAdjuvant Chemoradiotherapy for rectal cancer: a multicenter randomized controlled parallel group trial (TiMiSNAR) BMC Cancer. 2019;19:1215. doi: 10.1186/s12885-019-6271-3. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMC Cancer are provided here courtesy of BMC

RESOURCES